These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25230022)

  • 1. [Possibilities of molecular diagnosis of renal cell carcinoma].
    Junker K
    Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.
    Spector Y; Fridman E; Rosenwald S; Zilber S; Huang Y; Barshack I; Zion O; Mitchell H; Sanden M; Meiri E
    Mol Oncol; 2013 Jun; 7(3):732-8. PubMed ID: 23587442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of renal cell carcinoma.
    Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on classification of oncocytic neoplasms of the kidney.
    Oszwald A; Wasinger G; Zisser L; Compérat E
    Curr Opin Urol; 2023 May; 33(3):239-244. PubMed ID: 36660966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.
    Cheng L; Williamson SR; Zhang S; Maclennan GT; Montironi R; Lopez-Beltran A
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):843-64. PubMed ID: 20553210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
    Küfer R; Hautmann R
    Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
    [No Abstract]   [Full Text] [Related]  

  • 10. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of genetic markers in the management of kidney cancer.
    Junker K; Ficarra V; Kwon ED; Leibovich BC; Thompson RH; Oosterwijk E
    Eur Urol; 2013 Feb; 63(2):333-40. PubMed ID: 23040205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
    Al-Ali BM; Ress AL; Gerger A; Pichler M
    Anticancer Res; 2012 Sep; 32(9):3727-32. PubMed ID: 22993312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of renal neoplasms based on molecular signatures.
    Yang XJ; Sugimura J; Schafernak KT; Tretiakova MS; Han M; Vogelzang NJ; Furge K; Teh BT
    J Urol; 2006 Jun; 175(6):2302-6. PubMed ID: 16697863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-210 is a prognostic marker in clear cell renal cell carcinoma.
    Samaan S; Khella HW; Girgis A; Scorilas A; Lianidou E; Gabril M; Krylov SN; Jewett M; Bjarnason GA; El-said H; Yousef GM
    J Mol Diagn; 2015 Mar; 17(2):136-44. PubMed ID: 25555365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophobe renal cell carcinoma: a review of an uncommon entity.
    Vera-Badillo FE; Conde E; Duran I
    Int J Urol; 2012 Oct; 19(10):894-900. PubMed ID: 22715810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
    Sültmann H; Poustka A
    Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.